20 March 2019 in Current Infectious Disease Reports
1 September 2021 in American Journal of Pharmaceutical Education
Objective. Describe development and current structure of an advanced pharmacy practice experience (APPE) in leadership. Methods. Our leadership APPE evolved from mostly content-oriented delivery to an experiential offering by identifying and implementing rich practical leadership experiences over time. After five years of developing and refining the APPE, faculty coordinators sought student feedback on the current leadership rotation beyond using the standardized APPE evaluation students complete at the end of rotations. Data were analyzed and reported as means of agreement for quantitative items, and open-ended responses were analyzed by latent thematic analysis. Results. Current APPE topics include PhotoVoice, Power of Full Engagement, What’s Your Passion, Transformational Leadership, Speech Acts, a Mindfulness Retreat, PeoplePack Dynamics, a rowing experience at an Olympic training facility, and more. Overall, students positively agreed with all evaluation items. Items with highest mean agreement included: early course concepts were reinforced in the rotation; relevance of the rotation to one’s career; rotation objectives facilitated learning; and a variety of teaching methods helped in applying knowledge to future practice. Analysis of comments regarding the rotation overall identified three main themes of Gratitude, Development, and More Connection, along with various subthemes. Conclusion. An APPE elective with a primary purpose of leadership training and development can be created for experiential learning. We present a summary of the history, development, and current practices of a leadership APPE that can serve as an example for institutions in the implementation of leadership offerings for student pharmacists.
11 December 2019 in Journal of the Pediatric Infectious Diseases Society
Cefdinir is frequently prescribed for pediatric infections despite lack of first-line indications. We reviewed Kentucky Medicaid claims from 2012 through 2016. Cefdinir prescriptions and spending significantly increased over the study period. Upper respiratory infections accounted for the majority of use. Inappropriate cefdinir use should be a priority for stewardship efforts.
15 June 2022 in Antimicrobial Stewardship & Healthcare Epidemiology
Objective: To describe pediatric outpatient visits and antibiotic prescribing during the coronavirus disease 2019 (COVID-19) pandemic. Design: An observational, retrospective control study from January 2019 to October 2021. Setting: Outpatient clinics, including 27 family medicine clinics, 27 pediatric clinics, and 26 urgent or prompt care clinics. Patients: Children aged 0–19 years receiving care in an outpatient setting. Methods: Data were extracted from the electronic health record. The COVID-19 era was defined as April 1, 2020, to October 31, 2021. Virtual visits were identified by coded encounter or visit type variables. Visit diagnoses were assigned using a 3-tier classification system based on appropriateness of antibiotic prescribing and a subanalysis of respiratory visits was performed to compare changes in the COVID-19 era compared to baseline. Results: Through October 2021, we detected an overall sustained reduction of 18.2% in antibiotic prescribing to children. Disproportionate changes occurred in the percentages of antibiotic visits in respiratory visits for children by age, race or ethnicity, practice setting, and prescriber type. Virtual visits were minimal during the study period but did not result in higher rates of antibiotic visits or in-person follow-up visits. Conclusions: These findings suggest that reductions in antibiotic prescribing have been sustained despite increases in outpatient visits. However, additional studies are warranted to better understand disproportionate rates of antibiotic visits.
1 September 2004 in American Journal of Psychiatry
26 May 2022 in JAMA Network Open
It is well-known that inappropriate antibiotic prescribing is common in outpatient settings. In addition to potentiating the development of antimicrobial resist